Kasuga A, Takei I, Tasaka S, Shibata H, Maruyama H, Saruta T, Kataoka K
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Endocr J. 1993 Feb;40(1):47-52. doi: 10.1507/endocrj.40.47.
A 62-year-old patient with non-insulin dependent diabetes (NIDDM) was admitted to our hospital for blood pressure control. He had been treated with angiotensin converting enzyme inhibitor (ACEI) for 7 years and showed marked hypokalemia with increased urinary potassium excretion. Hormonal examination revealed a normal plasma aldosterone concentration and increased plasma renin activity (PRA, 13.4 ng/ml/h), so potassium losing nephropathy was suspected. After discontinuation of the ACEI, PRA decreased to normal. An adrenal adenoma was found on abdominal magnetic resonance imaging (MRI) and adrenalectomy was performed to confirm aldosterone producing adenoma (APA). Although ACEIs are said not to alter PRA in APA, this drug was primarily responsible for the increased PRA in this case. This is a rare case of APA, which showed markedly increased PRA during ACEI treatment.
一名62岁的非胰岛素依赖型糖尿病(NIDDM)患者因血压控制问题入住我院。他接受血管紧张素转换酶抑制剂(ACEI)治疗7年,出现明显低钾血症,尿钾排泄增加。激素检查显示血浆醛固酮浓度正常,血浆肾素活性(PRA,13.4 ng/ml/h)升高,因此怀疑为失钾性肾病。停用ACEI后,PRA降至正常。腹部磁共振成像(MRI)发现肾上腺腺瘤,行肾上腺切除术以确诊醛固酮瘤(APA)。尽管据说ACEI不会改变APA患者的PRA,但该药物在本病例中是导致PRA升高的主要原因。这是一例罕见的APA病例,在ACEI治疗期间PRA显著升高。